Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Inability to walk, Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), and Irritability and others; and rarely findings: Damage to the optic nerve (optic atrophy). 25 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 11 | Poor speech, Inability to walk, Seizure |
FOXRED1 encodes FAD dependent oxidoreductase domain containing 1 (486 aa). Required for the assembly of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). Involved in mid-late stages of complex I assembly Highest expression in Brain Cerebellar Hemisphere (53.0 TPM) and Brain Cerebellum (47.0 TPM).
Mitochondrial complex I deficiency, nuclear type 19 is associated with mutations in the FOXRED1 gene on chromosome 11.
FOXRED1 is classified as a druggable target with score 0.0.
Genetic testing for FOXRED1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 13 always present features.
No clinical trials have been registered for mitochondrial complex I deficiency, nuclear type 19.
3 publications have been identified in PubMed for mitochondrial complex I deficiency, nuclear type 19. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (33%).
Kumari D (2026). [PMID: 41554758](https://pubmed.ncbi.nlm.nih.gov/41554758/). *Sci Rep*. [Basic Science / Preclinical]
Alhamad AR (2025). [PMID: 40709164](https://pubmed.ncbi.nlm.nih.gov/40709164/). *Cureus*. [Case Report / Case Series]
Zhang X (2024). [PMID: 39850733](https://pubmed.ncbi.nlm.nih.gov/39850733/). *Front Neurol*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 7:49 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles |
4 |
Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), Damage to the optic nerve (optic atrophy) |
Eyes | 2 | Cerebral visual impairment, Damage to the optic nerve (optic atrophy) |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Digestive system | 1 | Feeding difficulties |
Head and neck | 1 | Secondary microcephaly |
Lungs and breathing | 1 | Difficulty breathing (respiratory insufficiency) |
Lab test results | 1 | Decreased activity of mitochondrial complex I |
Heart and blood vessels | 1 | Thickened heart muscle (hypertrophic cardiomyopathy) |
Age of onset: newborn period, at birth, adolescence.